Yaghmaie is a corporate and securities partner
and co-head of the firm's Private Equity Practice
Team. Mr. Yaghmaies practice entails the
representation of private and publicly-held emerging
growth high technology and life science companies,
leading investment banks and venture capital funds,
with a particular focus on private placements
and venture financings, public offerings of equity
and debt securities, and mergers and acquisitions.
Mr. Yaghmaie has been involved in many of the
leading corporate and financing technology transactions
in the New York area, and regularly represents
numerous venture-backed companies and venture
capital funds. In addition, Mr. Yaghmaie has
represented both issuers and underwriters in
more than 30 public offerings by venture-backed
issuers across a variety of industries, including
public offerings by Albany Molecular Research,
Best Software, Emcore, Globix, Hologic, IDX,
Innovasive Devices, Knight/Trimark, Media Metrix,
Myriad Genetics, Predictive Systems, StarMedia,
Trimeris, Technitrol and Tellium.
Mr. Yaghmaie has served as counsel to many
leading investment banks, including Credit Suisse
First Boston, Deutsche Bank Securities, Goldman
Sachs, Hambrecht & Quist, Morgan Stanley,
Robertson Stephens and SG Cowen.
Mr. Yaghmaie is a faculty member of the Practicing
Law Institute and has authored the chapter in
the Securities Filings volume entitled, "Compliance
with the Securities Act in the Acquisition Context."
Mr. Yaghmaie is amongst the authors of the widely-used
book, Venture Capital & Public Offering
Negotiation, published by Aspen Law & Business.
He is also a senior contributing editor of VC
Experts' Venture Capital Encyclopedia, and a
member of the Advisory Boards of the Silicon
Alley Entrepreneurs Club, VC 2003 and the Young
Venture Capital Society.
Before joining Pillsbury Winthrop, Mr. Yaghmaie
was a co-founding partner of the New York office
of Wilson Sonsini Goodrich & Rosati.